About this trial
The purpose of this study is to collect and study key medical data about several ultra-rare GSDs (Glycogen Storage Diseases) including, but not limited to, GSD types 0a, 0b, VII, X, XII, XIII, XV, PRKAG2 syndrome and Danon disease.
Eligibility criteria
Qualifiers
Diagnosis of a rare GSD, including 0a, 0b, VII, X, XII, XIII, XV, PRKAG2 syndrome or Danon disease
Two variants in the gene associated with the specific GSD type (for autosomal recessive diseases)
One variant in the gene associated with the specific GSD type (for autosomal dominant or X-linked diseases)
Deficient enzyme activity in liver, muscle, skin fibroblast or other tissue
Disqualifiers
Unable to provide informed consent for participation for one's self or by legally authorized representative/legal guardian/parent
Trial design
Treatments tested in this trial
- No intervention
Treatment groups
Locations
1Sponsors and collaborators
Duke University
Lead sponsor